RU2016133688A - Композиции, содержащие экстракты Curcuma Longa и Echinacea angustifolia, которые являются полезными для уменьшения периферического воспаления и боли - Google Patents

Композиции, содержащие экстракты Curcuma Longa и Echinacea angustifolia, которые являются полезными для уменьшения периферического воспаления и боли Download PDF

Info

Publication number
RU2016133688A
RU2016133688A RU2016133688A RU2016133688A RU2016133688A RU 2016133688 A RU2016133688 A RU 2016133688A RU 2016133688 A RU2016133688 A RU 2016133688A RU 2016133688 A RU2016133688 A RU 2016133688A RU 2016133688 A RU2016133688 A RU 2016133688A
Authority
RU
Russia
Prior art keywords
extract
composition according
curcumin
echinacea
amounts ranging
Prior art date
Application number
RU2016133688A
Other languages
English (en)
Other versions
RU2677894C2 (ru
RU2016133688A3 (ru
Inventor
Эцио БОМБАРДЕЛЛИ
Original Assignee
Индена С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Индена С.П.А. filed Critical Индена С.П.А.
Publication of RU2016133688A publication Critical patent/RU2016133688A/ru
Publication of RU2016133688A3 publication Critical patent/RU2016133688A3/ru
Application granted granted Critical
Publication of RU2677894C2 publication Critical patent/RU2677894C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/758Zanthoxylum, e.g. pricklyash
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (11)

1. Композиции, по существу состоящие из экстракта Curcuma spp или куркумина и экстракта, выбранного из экстракта Echinacea angustifolia или липофильного экстракта Zanthoxylum bungeanum, смешанных с приемлемыми эксципиентами.
2. Композиции по п. 1, где куркумин образует комплекс с фосфолипидами.
3. Композиции по п. 1, где экстракты Echinacea angustifolia и Zanthoxylum bungeanum получены путем экстрагирования сверхкритическим диоксидом углерода.
4. Композиции по пп. 1-3 для перорального введения.
5. Композиции по п. 4, содержащие в качестве единственных активных ингредиентов куркумин в комплексе с фосфолипидами в количествах, находящихся в диапазоне от 100 до 1000 мг, и экстракт Echinacea в количествах, находящихся в диапазоне от 1 до 20 мг, или, альтернативно, липофильный экстракт Zanthoxylum spp. в количествах, находящихся в диапазоне от 5 до 25 мг, на пероральную стандартную дозу.
6. Композиции по п. 5, содержащие в качестве единственных активных ингредиентов 500 мг куркумина в комплексе с фосфолипидами и 5 мг экстракта Echinacea или, альтернативно, 10 мг липофильного экстракта Zanthoxylum spp., на пероральную стандартную дозу.
7. Композиции по пп. 1-3 для местного введения.
8. Композиции по п. 7, содержащие куркумин в комплексе с фосфолипидами в количествах, находящихся в диапазоне от 0,1% до 0,5% масс./масс., и экстракт Echinacea в количествах, находящихся в диапазоне от 0,05% до 0,5% масс./масс., или липофильный экстракт Zanthoxylum spp.в количествах, находящихся в диапазоне от 0,1 до 1% масс./масс..
9. Композиции по п. 8, содержащие 0,2% масс./масс. куркумина в комплексе с фосфолипидами и 0,2% масс./масс. экстракта Echinacea или, альтернативно, 0,5% масс./масс. липофильнгого экстракта Zanthoxylum spp.
10. Композиции по пп. 1-9 для применения в лечении периферической боли, суставной и мышечной боли, воспалительных, и поверхностных, и глубоких болевых состояний.
11. Композиции по п. 10 для лечения остеоартрита и ревматоидного артрита.
RU2016133688A 2014-02-20 2015-02-18 Композиции, содержащие экстракты Curcuma Longa и Echinacea angustifolia, которые являются полезными для уменьшения периферического воспаления и боли RU2677894C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2014A000251 2014-02-20
ITMI20140251 2014-02-20
PCT/EP2015/053399 WO2015124616A1 (en) 2014-02-20 2015-02-18 Compositions containing extracts of curcuma longa and echinacea angustifolia which are useful to reduce peripheral inflammation and pain

Publications (3)

Publication Number Publication Date
RU2016133688A true RU2016133688A (ru) 2018-03-23
RU2016133688A3 RU2016133688A3 (ru) 2018-08-30
RU2677894C2 RU2677894C2 (ru) 2019-01-22

Family

ID=50336467

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016133688A RU2677894C2 (ru) 2014-02-20 2015-02-18 Композиции, содержащие экстракты Curcuma Longa и Echinacea angustifolia, которые являются полезными для уменьшения периферического воспаления и боли

Country Status (19)

Country Link
US (1) US10286028B2 (ru)
EP (1) EP3107555B1 (ru)
JP (1) JP6510544B2 (ru)
KR (1) KR102350519B1 (ru)
CN (1) CN106029082A (ru)
AU (1) AU2015220913B2 (ru)
BR (1) BR112016018973B1 (ru)
CA (1) CA2939976C (ru)
DK (1) DK3107555T3 (ru)
ES (1) ES2804324T3 (ru)
HU (1) HUE051696T2 (ru)
IL (1) IL247314B (ru)
MX (1) MX2016010722A (ru)
PL (1) PL3107555T3 (ru)
PT (1) PT3107555T (ru)
RU (1) RU2677894C2 (ru)
SG (1) SG11201606831PA (ru)
SI (1) SI3107555T1 (ru)
WO (1) WO2015124616A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3150214A1 (en) * 2015-10-01 2017-04-05 INDENA S.p.A. Compositions containing extracts of curcuma spp and zingiber officinale which are useful to reduce peripheral inflammation and pain
AU2016373576B2 (en) * 2015-12-16 2022-06-02 Vivek Anand PARACHUR Tri-molecular complex of natural compounds
ITUB20161030A1 (it) 2016-02-24 2017-08-24 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore
US10744174B1 (en) * 2016-03-16 2020-08-18 Robert Alonso Composition(s) and method(s) for topically treating pain
ITUA20164757A1 (it) 2016-06-29 2017-12-29 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore osteoarticolare e del danno cartilagineo
JP6987528B2 (ja) * 2017-05-12 2022-01-05 小林製薬株式会社 クルクミノイド含有錠剤
KR102020667B1 (ko) * 2017-09-29 2019-09-10 유씨엘 주식회사 두피염증 예방 및 완화, 및 탈모방지 효과가 있는 화장료 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2075187T3 (es) * 1990-07-05 1995-10-01 Indena Spa Extractos de equinaceas, un procedimiento para su preparacion y formulaciones que los contienen.
US6440448B1 (en) * 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
ITMI981542A1 (it) * 1998-07-07 2000-01-07 Indena Spa Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
JP5032003B2 (ja) 2005-06-15 2012-09-26 株式会社琉球バイオリソース開発 口腔粘膜用の鎮痛・抗炎症トローチ剤
EP1837030A1 (en) * 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
ITMI20071136A1 (it) * 2007-06-04 2008-12-05 Velleja Res Srl Formulazioni topiche per la prevenzione e il trattamento degli stati infiammatori e/o infettivi dell'aera genitale
KR20090047637A (ko) 2007-11-08 2009-05-13 재단법인서울대학교산학협력재단 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물
CN101607068A (zh) * 2009-07-15 2009-12-23 中国人民解放军第四军医大学 一种治疗肝癌中药前体脂质体注射剂及其制备工艺
IT1401141B1 (it) * 2010-07-26 2013-07-12 Indena Spa Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico

Also Published As

Publication number Publication date
RU2677894C2 (ru) 2019-01-22
SI3107555T1 (sl) 2020-07-31
AU2015220913B2 (en) 2020-04-09
IL247314B (en) 2020-08-31
KR20160113631A (ko) 2016-09-30
CN106029082A (zh) 2016-10-12
JP6510544B2 (ja) 2019-05-08
KR102350519B1 (ko) 2022-01-14
HUE051696T2 (hu) 2021-03-29
EP3107555B1 (en) 2020-06-03
WO2015124616A1 (en) 2015-08-27
JP2017506241A (ja) 2017-03-02
ES2804324T3 (es) 2021-02-05
MX2016010722A (es) 2016-11-10
US10286028B2 (en) 2019-05-14
DK3107555T3 (da) 2020-08-10
PL3107555T3 (pl) 2020-11-30
SG11201606831PA (en) 2016-09-29
RU2016133688A3 (ru) 2018-08-30
EP3107555A1 (en) 2016-12-28
PT3107555T (pt) 2020-07-10
IL247314A0 (en) 2016-09-29
US20170049840A1 (en) 2017-02-23
AU2015220913A1 (en) 2016-09-01
CA2939976C (en) 2023-09-05
CA2939976A1 (en) 2015-08-27
BR112016018973B1 (pt) 2021-01-19

Similar Documents

Publication Publication Date Title
RU2016133688A (ru) Композиции, содержащие экстракты Curcuma Longa и Echinacea angustifolia, которые являются полезными для уменьшения периферического воспаления и боли
MX2016010213A (es) Formulaciones farmaceuticas novedosas.
WO2015160842A8 (en) Methods and formulations of capsaicinoids and capsinoids
WO2015159272A3 (en) Curcumin compositions and uses thereof
PH12017502325A1 (en) Orodispersible dosage unit containing an estetrol component
WO2013183062A3 (en) Palatable formulations of ibuprofen
MX2017015879A (es) Composiciones de hidroxipropil beta-ciclodextrina y metodos.
BR112017009510A2 (pt) composições compreendendo ciclosporina
CL2021003291A1 (es) Mezcla de extractos de plantas para su uso en la prevención y/o tratamiento de enfermedades inflamatorias crónicas del intestino.
HRP20211160T1 (hr) Kompozicije koje sadrže geraniol i suhi đumbir za uporabu u liječenju sindroma iritabilnog crijeva
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
MX2011011959A (es) Emulsion aceite en agua de mometasona y propilenglicol.
MX2019000255A (es) Composiciones farmaceuticas.
WO2016073326A3 (en) Methods and compositions for treating and preventing arthritis
AR102295A1 (es) Compuesto derivado de pirazolina y su uso en un régimen de dosificación semanal contra inflamación y dolor derivados de enfermedad articular degenerativa en mamíferos
WO2015166418A3 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
BR112014017544A2 (pt) fitocomposição para o tratamento de dores relacionadas com doenças das articulações
MX2019007078A (es) Procedimiento para la preparacion de composiciones en polvo.
IT201700035757A1 (it) Composizioni contenenti principi attivi naturali, loro preparazione ed uso nel trattamento della stipsi
RU2018130117A (ru) Композиции, полезные в предупреждении и/или лечении воспаления и боли
HRP20160811T1 (hr) Upotreba odiparcila u liječenju mukopolisaharidoze
LIU et al. Anti-fatigue effects of N-benzylhexadecanamide and Maca extract in mice
WO2016027225A8 (en) A composition having a muscle-relaxant and anti-inflammatory activity
JP2016527284A5 (ru)
HRP20231254T1 (hr) Kompozicije koje sadrže ekstrakt lipida dagnјi i ulje krila, i nјihove medicinske primjene